BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3087235)

  • 21. 99mTc-labelled compounds prepared with antimony(III) as reducing agent.
    Vilcek S; Machán V; Kalincák M
    Radiobiol Radiother (Berl); 1983; 24(1):103-8. PubMed ID: 6407061
    [No Abstract]   [Full Text] [Related]  

  • 22. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
    Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
    Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative distribution of diphosphonate between bone and soft tissue at 4 and 24 hours: concise communication.
    Smith ML; Martin W; Fogelman I; Bessent RG
    J Nucl Med; 1983 Mar; 24(3):208-11. PubMed ID: 6402571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Scintigraphic detection of experimental myocardial infarct using 99mTC-hydroxyethylidine diphosphonate (99mTc-EHDP)].
    Duska F; Mazurová Y; Palicka V; Kajka P; Vizd'a J; Kubícek J
    Cesk Radiol; 1986 Mar; 40(2):102-8. PubMed ID: 3082525
    [No Abstract]   [Full Text] [Related]  

  • 25. Preparation and characterization of two complexes of technetium with 2-mercaptocarboxylic acids.
    Livni E; Davis MA; Warner VD
    J Nucl Med; 1981 Jun; 22(6):535-7. PubMed ID: 7229724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The chemical state of 99m Tc in biomedical products. II. The chelation of reduced technetium with DTPA.
    Eckelman WC; Meinken G; Richards P
    J Nucl Med; 1972 Aug; 13(8):577-81. PubMed ID: 5041632
    [No Abstract]   [Full Text] [Related]  

  • 27. Factors affecting the labeling efficiency and stability of technetium-99m-labeled glucoheptonate.
    Zbrzeznj DJ; Khan RA
    Am J Hosp Pharm; 1981 Oct; 38(10):1499-502. PubMed ID: 7294045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 99m technetium diphosphonate bone scanning of the mandibular bone graft.
    Lee HK; Markowitz J
    Oral Surg Oral Med Oral Pathol; 1980 May; 49(5):471-3. PubMed ID: 6769081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technetium-99m N,N'-bis(2-mercapto-2-methylpropyl)-2-aminobenzylamine: technetium-99m complexes of a novel bis(aminoethanethiol) ligand.
    Francesconi LC; Yang YY; Kung MP; Zhang XX; Billings JJ; Guo YZ; Kung HF
    J Med Chem; 1994 Sep; 37(20):3282-8. PubMed ID: 7932555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scintiphotos in rabbits made with Tc-99m preparations reduced by electrolysis and by SnCl2: concise communication.
    Steigman J; Chin EV; Solomon NA
    J Nucl Med; 1979 Jul; 20(7):766-70. PubMed ID: 232150
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc.
    Hambright P; McRae J; Valk PE; Bearden AJ; Shipley BA
    J Nucl Med; 1975 Jun; 16(6):478-82. PubMed ID: 808594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukocyte labeling with technetium-99m tin colloids.
    Hanna R; Lomas F; Sullivan P
    J Nucl Med; 1988 May; 29(5):729-30. PubMed ID: 3373309
    [No Abstract]   [Full Text] [Related]  

  • 33. Complexes of technetium with hydroxycarboxylic acids: gluconic, glucoheptonic, tartaric, and citric.
    Russell CD; Speiser AG
    J Nucl Med; 1980 Nov; 21(11):1086-90. PubMed ID: 7431109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The separation of 99mTc(Sn)EHDP complexes by HPLC and GPC.
    de Groot GJ; Das HA; de Ligny CL
    Int J Rad Appl Instrum A; 1986; 37(1):23-7. PubMed ID: 3019923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukocyte labeling with technetium-99m tin colloids.
    Mock BH; English D
    J Nucl Med; 1987 Sep; 28(9):1471-7. PubMed ID: 3625299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time dependence of iprofenin-labeling with technetium Tc 99m.
    Ponto JA; Ponto LL
    Am J Hosp Pharm; 1981 Dec; 38(12):1939-41. PubMed ID: 7325178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Raman spectroscopic evidence for Tc-oxo cores in Tc-HEDP complexes.
    Mikelsons MV; Pinkerton TC
    Int J Rad Appl Instrum A; 1987; 38(7):569-70. PubMed ID: 3040638
    [No Abstract]   [Full Text] [Related]  

  • 38. Interaction of stannous ion with pyrrolidino-methyl tetracycline (PMT) in the preparation of PMT-99mTc radiopharmaceuticals.
    Zmbova B; Zivanov-Stakić D; Tadzer I
    Int J Appl Radiat Isot; 1981 Jul; 32(7):459-63. PubMed ID: 7263095
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diagnostic significance of electrocardiography and myocardial scintigraphy with 99m Tc-Sn-pyrophosphate and 99m Tc-Sn-phosphone in patients with stenocardia].
    Zudbinov IuI; Ponomareva AG; Sokolov OK
    Med Radiol (Mosk); 1986 Aug; 31(8):22-6. PubMed ID: 3091990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo labeling of red blood cells with Tc-99m with stannous pyridoxylideneaminates.
    Kato M
    J Nucl Med; 1979 Oct; 20(10):1071-4. PubMed ID: 536758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.